CT-based Model for Predicting Prolonged Weaning in Patients With Abdominal Trauma
Launched by JINLING HOSPITAL, CHINA · Mar 28, 2024
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (1) with information on survival status and time;
- • (2) aged 18-80 years;
- • (3) admitted to ICU;
- • (4) with abdominal CT performed within 1-week post-trauma;
- • (5) use of mechanical ventilation.
- Exclusion Criteria:
- • (1) low-quality CT images;
- • (2) history of mental illness.
About Jinling Hospital, China
Jinling Hospital, located in Nanjing, China, is a prominent healthcare institution renowned for its commitment to advanced medical research and comprehensive patient care. As a key clinical trial sponsor, Jinling Hospital leverages its robust clinical expertise and state-of-the-art facilities to facilitate innovative research initiatives that aim to improve therapeutic outcomes across various medical fields. With a dedicated team of experienced researchers and healthcare professionals, the hospital fosters collaboration and adheres to rigorous ethical standards, ensuring the integrity and quality of its clinical trials while contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported